Harmony Stock Performance

The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. Let's try to break down what Harmony's beta means in this case. the returns on MARKET and Harmony Biosciences are completely uncorrelated. Although it is extremely important to respect Harmony Biosciences current price history, it is better to be realistic regarding the information on equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating Harmony Biosciences technical indicators, you can presently evaluate if the expected return of 0.0% will be sustainable into the future. Harmony Biosciences right now retains a risk of 0.0%. Please check out Harmony Biosciences variance and potential upside to decide if Harmony Biosciences will be following its current trending patterns.

Harmony Stock Performance 

 
Refresh
 Harmony Performance
0 of 100
Over the last 90 days Harmony Biosciences Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Harmony Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Quick Ratio4.93
Fifty Two Week Low25.09
Target High Price57.00
Fifty Two Week High52.74
Target Low Price43.00

Harmony Biosciences Relative Risk vs. Return Landscape

If you would invest (100.00)  in Harmony Biosciences Holdings on July 24, 2021 and sell it today you would earn a total of  100.00  from holding Harmony Biosciences Holdings or generate -100.0% return on investment over 90 days. Harmony Biosciences Holdings is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Harmony, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 

Harmony Biosciences Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Harmony Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Harmony Biosciences Holdings, and traders can use it to determine the average amount a Harmony Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
HRMY
Based on monthly moving average Harmony Biosciences is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Harmony Biosciences by adding it to a well-diversified portfolio.

Things to note about Harmony Biosciences

Checking the ongoing alerts about Harmony Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Harmony Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Harmony Biosciences Alerts

Equity Alerts and Improvement Suggestions

Harmony Biosciences is not yet fully synchronised with the market data
Harmony Biosciences has some characteristics of a very speculative penny stock
The company reported the previous year's revenue of 199.58 M. Net Loss for the year was (7.4 M) with profit before overhead, payroll, taxes, and interest of 132 M.
About 75.0% of the company shares are owned by institutional investors
Check out Risk vs Return Analysis. Note that the Harmony Biosciences information on this page should be used as a complementary analysis to other Harmony Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Tools for Harmony Stock

When running Harmony Biosciences price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go